AXERT® (almotriptan malate) Tablets PRESCRIBING INFORMATION

First Page		Document Content
Date: 2009-04-21 16:03:17 Almotriptan Migraine Venlafaxine Angina pectoris Myocardial infarction Coronary artery disease Methadone Discovery and development of triptans Triptans Chemistry Organic chemistry		AXERT® (almotriptan malate) Tablets PRESCRIBING INFORMATION Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 292,98 KB Share Document on Facebook

	REVIEW ARTICLE Relationship between time of initial diagnosis of acute myocardial infarction to primary angioplasty on patient’s outcome Marianna Saita RN, BSN, MSc1, George Argyriou RN, MSc, PhD2, Olga Kadda RN, MSc, DocID: 1vs1z - View Document
	Dewar D. Finlay et al.: Classification of Body Surface Potential Maps: A Comparison of Isointegral Measurements in the Diagnosis of Old Myocardial Infarction, en 7-12 en7 Classification of Body Surface Potential Maps: A DocID: 1uHGU - View Document
	ORIGINAL ARTICLE Thrombolysis in myocardial infarction (TIMI) risk score validation in Saudi Arabia Saad Al-Bugami, Faisal Al-Husayni, Samer Alamri, Rakan Aljedaani, Mohammad Zwawy, Abdulaziz Al-Zahrani DocID: 1um2b - View Document
	Electrocardiographic prediction of extensive lateral involvement in acute non-anterior wall myocardial infarction Stephen Nordaª, Kirian van der Wegb, Anton PM Gorgelsª a b DocID: 1rRLO - View Document
	Zusammenfassung der Master-Thesis von Caroline Bähler-Baumgartner Risk Factors Profile in Patients Admitted for Myocardial Infarction between 1999 andAusgangslage: Die Herz-Kreislauf-Krankheiten, zu welchen auch DocID: 1rD6f - View Document